Screener
Baxter International BAX Healthcare Systems & Technologies — Research and development expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Baxter International’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:50 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028962
| (in millions) | Three Months Ended March 31, 2026 / Medical Products & Therapies | Three Months Ended March 31, 2026 / Healthcare Systems & Technologies | Three Months Ended March 31, 2026 / Pharmaceuticals | Three Months Ended March 31, 2025 / Medical Products & Therapies | Three Months Ended March 31, 2025 / Healthcare Systems & Technologies | Three Months Ended March 31, 2025 / Pharmaceuticals |
|---|---|---|---|---|---|---|
| Net sales | $1,285 | $705 | $621 | $1,262 | $704 | $581 |
| Cost of sales | 781 | 390 | 458 | 694 | 356 | 396 |
| Selling, general and administrative expenses | 290 | 209 | 102 | 286 | 217 | 103 |
| Research and development expenses | 54 | 49 | 22 | 59 | 45 | 26 |
| Other segment items | (26) | (9) | (7) | (21) | (7) | (7) |
| Segment operating income | $186 | $66 | $46 | $244 | $93 | $63 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Baxter International's healthcare systems & technologies — research and development expenses?
- Baxter International (BAX) reported healthcare systems & technologies — research and development expenses of $49M in Q1 2026.
- How has Baxter International's healthcare systems & technologies — research and development expenses changed year-over-year?
- Baxter International's healthcare systems & technologies — research and development expenses increased by 8.9% year-over-year, from $45M to $49M.
- What is the long-term trend for Baxter International's healthcare systems & technologies — research and development expenses?
- Over 3 years (2022 to 2025), Baxter International's healthcare systems & technologies — research and development expenses has grown at a 7.0% compound annual growth rate (CAGR), from $155M to $190M.
- What does healthcare systems & technologies — research and development expenses mean?
- Represents investments in the innovation, design, and clinical validation of new medical technologies and digital health applications. This spending is critical for maintaining long-term competitiveness and product pipeline growth.
Ask your AI about Baxter International's healthcare systems & technologies — research and development expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude